New Delhi: Dr. Harsh Vardhan, Union Minister of Health
& Family Welfare chaired a high-level review meeting with senior officials
of the Ministry, MS/Director of Central Government Hospitals such as
Safdurjung, Dr. RML Hospital, and AIIMS, here today.
At the outset, the Union Health Minister appreciated the
various actions being undertaken in close coordination with various ministries
at the central level, States as well as Indian embassies abroad. He also lauded
the States for active surveillance, effective contact tracing and their
preparedness for containment and management of COVID-19.
He reviewed the preparedness regarding hospital
management such as OPD blocks, availability of testing kits, personal
protective equipment (PPEs), medicines, and adequate isolation wards. He
directed hospitals to ensure adequate availability of protective gear for all
healthcare workers. He was informed that adequate quantity of Personal
Protections Equipment (PPE), masks, sanitizers, handheld thermometers, etc.,
are being procured and provided to the designated places as per demand along
with maintaining the stock to address any future demand.
Dr. Harsh Vardhan reviewed in great detail the quarantine
facilities for the evacuees including the ones at the airports/other key
transit points, in terms of segregation of passengers, transportation to the
quarantine facilities, health check-ups, etc. The Health Minister has directed
for teams to be deputed to regularly inspect and monitor the quarantine
facilities to ensure that the necessary amenities and facilities are being
provided. The Minister stated that he shall be reviewing the same every day with
the aim of improving them. He further added that he is reviewing the situation
with the respective States/UTs.
Highlighting the critical importance of effective
communication as a tool of crisis management, Dr. Harsh Vardhan advised for
multi-media communication campaigns that would focus on different aspects such
as preventive measures, busting myths, equipping the masses with information on
guidelines, advisories, testing labs, etc.
No comments:
Post a Comment